NKT cells provide help for dendritic cell-dependent priming of MHC class I-Restricted CD8+ T cells in vivo

Journal of Immunology

Volumn 170, Issue 5, 2003, Pages 2540-2548

  Stober, Detlef ^a   Jomantaite, Ieva ^a   Schirmbeck, Reinhold ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD8 ANTIGEN; CERAMIDE DERIVATIVE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG ACTIVITY; IMMUNE RESPONSE; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0037371115     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.5.2540     Document Type: Article

References (73)

1. + cytolytic T cell responses. J. Exp. Med. 182:1663.
2. Ludewig, B., S. Ehl, U. Karrer, B. Odermatt, H. Hengartner, and R. M. Zinkernagel. 1998. Dendritic cells efficiently induce protective antiviral immunity. J. Virol. 72:3812.
3. Dhodapkar, M. V., R. M. Steinman, M. Sapp, H. Desai, C. Fossella, J. Krasovsky, S. M. Donahoe, P. R. Dunbar, V. Cerundolo, D. F. Nixon, and N. Bhardwaj. 1999. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Invest. 104:173.
4. - dendritic cells in vivo. Eur. J. Immunol. 29:3762.
5. Thurner, B., I. Haendle, C. Roder, D. Dieckmann, P. Keikavoussi, H. Jonuleit, A. Bender, C. Maczek, D. Schreiner, P. von-den-Driesch, et al. 1999. Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190:1669.
6. - dendritic cells. J. Immunol. 167:4215.
7. + T cells by infected dendritic cells in vivo. Nat. Immun. 3:265.
8. + T cell help. J. Immunol. 147:4069.
9. + T cell help. J. Exp. Med. 186:65.
10. Livingstone, A. M., and M. Kuhn. 1999. Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens. Eur. J. Immunol. 29:2826.
11. + T cell-dependent. J. Immunol. 163:1880.
12. + T cell help to elicit protective and therapeutic antitumor immunity. J. Immunol. 162:144.
13. den Boer, A. T., L. Diehl, G. J. van Mierlo, E. I. van der Voort, M. F. Fransen, P. Krimpenfort, C. J. Melief, R. Offringa, and R. E. Toes. 2001. Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus tolerance. J. Immunol. 167:2522.
14. + T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity. J. Immunol. 165: 6047.
15. + T cells. J. Immunol. 160:2896.
16. Di, R. F., and P. Matzinger. 1996. Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. J. Exp. Med. 183:2153.
17. + T cell numbers are maintained during γ-herpes virus reactivation in CD4-deficient mice. Proc. Natl. Acad. Sci. USA 95:15565.
18. + T cell memory. J. Immunol. 164:3274.
19. + T-helper and a T-killer cell. Nature 393: 474.
20. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
21. Ossendorp, F., E. Mengede, M. Camps, R. Filius, and C. J. Melief. 1998. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J. Exp. Med. 187:693.
22. -/- dendritic cells to provide tumor protection is rescued by CD40 ligation. J. Immunol. 163:77.
23. + cytotoxic T lymphocytes. J. Exp. Med. 191:541.
24. + cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J. Exp. Med. 192:145.
25. Sato, M., K. Chamoto, T. Tsuji, Y. Iwakura, Y. Togashi, T. Koda, and T. Nishimura. 2001. Th1 cytokine-conditioned bone marrow-derived dendritic cells can bypass the requirement for Th functions during the generation of CD8 CTL. J. Immunol. 167:3687.
26. Oxenius, A., M. M. Martinic, H. Hengartner, and P. Klenerman. 1999. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J. Virol. 73:4120.
27. Cho, H. J., K. Takabayashi, P. M. Cheng, M. D. Nguyen, M. Corr, S. Tuck, and E. Raz. 2000. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat. Biotechnol. 18: 509.
28. Gumperz, J. E., and M. B. Brenner. 2001. CD1-specific T cells in microbial immunity. Curr. Opin. Immunol. 13:471.
29. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1521.
30. Joyce, S. 2000. Natural T cells: cranking up the immune system by prompt cytokine secretion. Proc. Natl. Acad. Sci. USA 97:6933.
31. Bendelac, A., and R. Medzhitov. 2002. Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J. Exp. Med. 195:F19.
32. Eberl, G., and H. R. MacDonald. 2000. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30:985.
33. + T cells upon NK T or T cell activation. J. Immunol. 165:4305.
34. Burdin, N., L. Brossay, and M. Kronenberg. 1999. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29:2014.
35. Singh, N., S. Hong, D. C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. Van-Kaer. 1999. Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163:2373.
36. Nishimura, T., H. Kitamura, K. Iwakabe, T. Yahata, A. Ohta, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, et al. 2000. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12:987.
37. Gonzalez, A., C. de Oliveira, M. Tomaska, S. Hong, R. O. Bruna, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van-Kaer, Y. Koezuka, and M. Tsuji. 2000. α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97:8461.
38. Smyth, M. J., M. Taniguchi, and S. E. Street. 2000. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J. Immunol. 165:2665.
39. Hayakawa, Y., K. Takeda, H. Yagita, S. Kakuta, Y. Iwakura, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur. J. Immunol. 31:1720.
40. Gonzalez-Aseguinolaza, G., L. Van Kaer, C. C. Bergmann, J. M. Wilson, J. Schmieg, M. Kronenberg, T. Nakayama, M. Taniguchi, Y. Koezuka, and M. Tsuji. 2002. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195:617.
41. + T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76:4294.
42. Toura, I., T. Kawano, Y. Akutsu, T. Nakayama, T. Ochiai, and M. Taniguchi. 1999. Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J. Immunol. 163:2387.
43. + NKT cells activated by α-glycosyl-ceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 164:4458.
44. Trobonjaca, Z., F. Leithäuser, P. Moller, R. Schirmbeck, and J. Reimann. 2001. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells. J. Immunol. 167:1413.
45. Trobonjaca, Z., A. Kroger, D. Stober, F. Leithäuser, P. Moller, H. Hauser, R. Schirmbeck, and J. Reimann. 2002. Activating immunity in the liver. II. IFN-β attenuates NK cell-dependent liver injury triggered by liver NKT cell activation. J. Immunol. 168:3763.
46. Smiley, S. T., M. H. Kaplan, and M. J. Grusby. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275:977.
47. Kontgen, F., G. Suss, C. Stewart, M. Steinmetz, and H. Bluethmann. 1993. Targeted disruption of the MHC class II Aα gene in C57BL/6 mice. Int. Immunol. 5:957.
48. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
49. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182:993.
50. Schirmbeck, R., J. Wild, and J. Reimann. 1998. Similar as well as distinct MHC-1-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen (HBsAg). Eur. J. Immunol. 28:4149.
51. Robertson, J. M., P. E. Jensen, and B. D. Evavold. 2000. DO11.10 and OT-11 T cells recognize a C-terminal ovalbumin 323-339 epitope. J. Immunol. 164:4706.
52. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
53. Stober, D., R. Schirmbeck, and J. Reimann. 2001. IL-12/IL-18-dependent IFN-γ release by murine dendritic cells. J. Immunol. 167:957.
54. Stober, D., Z. Trobonjaca, J. Reimann, and R. Schirmbeck. 2002. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells. Eur. J. Immunol. 32:1099.
55. Schirmbeck, R., J. Wild, D. Stober, H. E. Blum, F. V. Chisari, M. Geissler, and J. Reimann. 2000. Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen. J. Immunol. 164:4235.
56. Jakob, T., P. S. Walker, A. M. Krieg, M. C. Udey, and J. C. Vogel. 1998. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161:3042.
57. Sparwasser, T., E. S. Koch, R. M. Vabulas, K. Heeg, G. B. Lipford, J. W. Ellwart, and H. Wagner. 1998. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:2045.
58. Hartmann, G., G. J. Weiner, and A. M. Krieg. 1999. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 96:9305.
59. b-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen. Int. Immunol. 11:1093.
60. Askew. D., R. S. Chu, A. M. Krieg, and C. V. Harding. 2000. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. J. Immunol. 165:6889.
61. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647.
62. b-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. J. Immunol. 160:3163.
63. + T-cell in humans without foreign helper epitopes. J. Clin. Invest. 105:R9.
64. Schoenberger, S. P., R. E. Toes, V. E. van-der, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
65. + T cells in the development of T helper type 1 responses. J. Exp. Med. 195:473.
66. Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, and A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821.
67. Verdijk, R. M., T. Mutis, B. Esendam, J. Kamp, C. J. Melief, A. Brand, and E. Goulmy. 1999. Polyriboinosinic polyribocytidylic acid (polyl:C) induces stable maturation of functionally active human dendritic cells. J. Immunol. 163:57.
68. Vabulas, R. M., H. Pircher, G. B. Lipford, H. Hacker, and H. Wagner. 2000. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses. J. Immunol. 164:2372.
69. + T cells in IL-12-induced immune responses in vivo. J. Immunol. 160:16.
70. Kitamura, H., K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van-Kaer, et al. 1999. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing IL-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189:1121.
71. + effector function against intracellular infection. J. Exp. Med. 184:131.
72. van der Vliet, H. J., N. Nishi, Y. Koezuka, B. M. von Blomberg, A. J. van den Eertwegh, S. A. Porcelli, H. M. Pinedo, R. J. Scheper, and G. Giaccone. 2001. Potent expansion of human natural killer T cells using α-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J. Immunol. Methods 247:61.
73. Fujii, S. I., K. Shimizu, M. Kronenberg, and R. M. Steinman. 2002. Prolonged IFN-γ producing NKT response induced with α-galactosylceramide-loaded DCs. Nat. Immun. 3:867.